摘要 |
Disclosed is a compound of formula I e.g. 2-(1-(6-acetamidopyrimidine-4-carboxamido)ethyl)-N-( 5-chloro-4-(trifluoromethyl)pyridin-2-yl)thiazole-5-1H-carboxamide or a pharmaceutically acceptable salt thereof, wherein: disorder is selected from a proliferative disorder, a cardiac disorder, a neurodegenerative disorder, an autoimmune disorder, a condition associated with organ transplant, an inflammatory disorder, an immunologically-mediated disorder, a viral disease, or a bone disorder. |
申请人 |
MILLENNIUM PHARMACEUTICALS, INC.;SUNESIS PHARMACEUTICALS, INC. |
发明人 |
CHEN, WEIRONG;COSSROW, JENNIFER;FRANKLIN, LIOYD;GUAN, BING;JONES, JOHN HOWARD;KUMARAVEL, GNANASAMBANDAM;LANE, BENJAMIN;LITTKE, ADAM;LUGOVSKOY, ALEXEY;PENG, HAIRUO;POWELL, NOEL;RAIMUNDO, BRIAN;TANAKA, HIROKO;VESSELS, JEFFREY;WYNN, THOMAS;XIN, ZHILI |